However, S100a9K26R substantially reduced the inflammation and cardiac dysfunction induced by recombinant S100a9, indicating that lactylated S100a9 has a specific disadvantage in MI/R mice that differs from the effects of S100a9. Here, S100A9 is linked to myocardial infarction.